Detected ·
TYBR Health
$30M—
TYBR Health closed a $30M Series A round co-led by Mutual Capital Partners and Vensana Capital, with participation from Neovate Capital Partners, to expand commercial access to the B3 GEL® System and advance clinical studies in orthopedic surgery.
- Website
- www.tybrhealth.com
- linkedin.com/company/tybr-health
- Amount
- $30 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-28 12:05:59 UTC
- Signal ID
- fe4fa7cd-cb93-4f2b-b13b-e0662f45a1fe
As the API returns it
{
"id": "fe4fa7cd-cb93-4f2b-b13b-e0662f45a1fe",
"created_at": "2026-07-28T12:05:59.211424Z",
"company_name": "TYBR Health",
"company_website_url": "www.tybrhealth.com",
"company_linkedin_url": "https://www.linkedin.com/company/tybr-health",
"event_type": "funding",
"funding_amount": 30000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*TYBR Health closed a $30M Series A round co-led by Mutual Capital Partners and Vensana Capital, with participation from Neovate Capital Partners, to expand commercial access to the B3 GEL® System and advance clinical studies in orthopedic surgery.*"
}